Pfizer

The biggest question on most investors’ minds in the first half of 2021 has been ‘will inflation be transitory or lasting?’ While the issue is far from settled, the...

Earlier in the year, we found that Australia's best performing sectors of the past decade were healthcare and technology. They are both fan favourites given their...

The psychologists call it middle child syndrome. The firstborn gets the responsibilities and privileges. The youngest is the over-indulged baby. But what about the...

As the coronavirus pandemic rages throughout most corners of the globe, the race is heating up to obtain approval for an effective vaccine. In the last fortnight or...

Wow, what a week! Pfizer announces it has a vaccine almost set to go, and hasn’t the market reacted! Happily for our investors, The Montgomery Fund has already pivoted...

This week – less than a year after the COVID-19 coronavirus first emerged – biopharma companies Pfizer and BioNTech announced that their novel vaccine candidate for...